NECLIFE

Nectar Lifesciences

₹32.19
+ 1.86 (6.13%)
27 July, 2024 06:58 BSE: 532649 NSE: NECLIFE ISIN: INE023H01027

Start SIP in Nectar Lifesciences

Start SIP

Nectar Lifesciences Performance

Day Range

  • Low 31
  • High 33
₹ 32

52 Week Range

  • Low 22
  • High 46
₹ 32
  • Open Price31
  • Previous Close30
  • Volume2222401

Nectar Lifesciences Share Price

  • Over 1 Month -0.53%
  • Over 3 Month -6.01%
  • Over 6 Month -10.83%
  • Over 1 Year + 49.72%

Nectar Lifesciences Key Statistics

P/E Ratio 144.5
PEG Ratio 1.2
Market Cap Cr
Price to Book Ratio 0.7
EPS 0.2
Dividend 0
Relative Strength Index 60.33
Money Flow Index 42.7
MACD Signal -0.8
Average True Range 1.4
Nectar Lifesciences Financials
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 440452398394389
Operating Expenses Qtr Cr 393410371359369
Operating Profit Qtr Cr 4942273620
Depreciation Qtr Cr 1515151515
Interest Qtr Cr 2425211820
Tax Qtr Cr 11111-2
Net Profit Qtr Cr 12125
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 1,6991,567
Operating Expenses Annual Cr 1,5331,469
Operating Profit Annual in Cr 15355
Depreciation Cr 6159
Interest Annual Cr 8779
Tax Annual Cr 13-18
Net Profit Annual Cr 5-22
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 225133
Cash from Investing Activity Annual Cr -1752
Cash from Financing Annual Activity Cr -205-186
Net Cash Flow Annual Cr 20
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 1,0691,065
Fixed Assets Annual Cr 708740
Total Non Current Assets Annual Cr 907772
Total Current Assets Annual Cr 1,2841,417
Total Assets Annual Cr 2,1912,189
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 4847
ROE Annual % 0-2
ROCE Annual % 93
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 106
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 440452398394389
Operating Expenses Qtr Cr 393410371359371
Operating Profit Qtr Cr 4942273618
Depreciation Qtr Cr 1515151515
Interest Qtr Cr 2425211820
Tax Qtr Cr 11111-2
Net Profit Qtr Cr 12124
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 1,6991,567
Operating Expenses Annual Cr 1,5331,471
Operating Profit Annual in Cr 15353
Depreciation Cr 6159
Interest Annual Cr 8779
Tax Annual Cr 13-18
Net Profit Annual Cr 5-24
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 225134
Cash from Investing Activity Annual Cr -1752
Cash from Financing Annual Activity Cr -205-186
Net Cash Flow Annual Cr 20
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 1,0691,065
Fixed Assets Annual Cr 708740
Total Non Current Assets Annual Cr 907772
Total Current Assets Annual Cr 1,2841,417
Total Assets Annual Cr 2,1912,189
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 4847
ROE Annual % 0-2
ROCE Annual % 93
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 106

Nectar Lifesciences Technicals

EMA & SMA

Current Price
₹32.19
+ 1.86 (6.13%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹30.26
  • 50 Day
  • ₹31.38
  • 100 Day
  • ₹32.05
  • 200 Day
  • ₹31.03
  • 20 Day
  • ₹30.19
  • 50 Day
  • ₹31.62
  • 100 Day
  • ₹32.77
  • 200 Day
  • ₹31.87

Nectar Lifesciences Resistance and Support

PIVOT
₹31.93
Resistance
First Resistance 33.35
Second Resistance 34.52
Third Resistance 35.94
RSI 60.33
MFI 42.70
MACD Single Line -0.80
MACD -0.56
Support
First Support 30.76
Second Support 29.34
Third Supoort 28.17

Nectar Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,522,148 119,423,708 47.35
Week 939,561 42,439,979 45.17
1 Month 816,118 42,935,978 52.61
6 Month 1,139,559 49,456,852 43.4

Nectar Lifesciences Result Highlights

Nectar Lifesciences Synopsis

NSE-Medical-Generic Drugs

Nectar Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1523.67 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2023. Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664.
Market Cap 680
Sales 1,686
Shares in Float 12.56
No of funds 12
Yield 0.22
Book Value 0.64
U/D Vol ratio 1.2
LTDebt / Equity 13
Alpha 0.01
Beta 1.28

Nectar Lifesciences Shareholding Pattern

Owner NameJun-24Mar-24Dec-23Sep-23
Promoters 55.8%55.8%55.8%55.8%
Foreign Portfolio Investors 2.08%2.39%1.53%1.43%
Individual Investors 23.7%23.32%24.34%24.46%
Others 18.42%18.49%18.33%18.31%

Nectar Lifesciences Management

Name Designation
Mr. Sanjiv Goyal Chairman & Managing Director
Dr. Indu Pal Kaur Independent Director
Mr. Ajay Swaroop Independent Director
Dr. Rupinder Tewari Independent Director
Dr. Kuldip Kumar Bhasin Independent Director
Mr. Puneet Sud Whole Time Director
Ms. Meena Verma Nominee Director

Nectar Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nectar Lifesciences Corporate Action

Date Purpose Remarks
2024-05-15 Audited Results
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results
2023-08-14 Quarterly Results
2023-05-26 Audited Results & A.G.M.

Nectar Lifesciences MF Shareholding

Name Amount(cr)

Nectar Lifesciences FAQs

What is Share Price of Nectar Lifesciences ?

Nectar Lifesciences share price is ₹32 As on 27 July, 2024 | 06:44

What is the Market Cap of Nectar Lifesciences ?

The Market Cap of Nectar Lifesciences is ₹721.9 Cr As on 27 July, 2024 | 06:44

What is the P/E ratio of Nectar Lifesciences ?

The P/E ratio of Nectar Lifesciences is 144.5 As on 27 July, 2024 | 06:44

What is the PB ratio of Nectar Lifesciences ?

The PB ratio of Nectar Lifesciences is 0.7 As on 27 July, 2024 | 06:44

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91